Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,601
datasets available to search
ShareScore release 0.9.0
Dataset results
1,601 results for “Prognosis;”
Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.
ClinicalTrials.gov study NCT04792138. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)
ClinicalTrials.gov study NCT06738758. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors
ClinicalTrials.gov study NCT00399399. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Impact of Persistent Microvascular Obstruction by Cardiac Magnetic Resonance on Prognosis for ST-segment Elevation Myocardial Infarction
ClinicalTrials.gov study NCT06759532. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
Postoperative Score Predictive of the Prognosis of Acetabular Fractures
ClinicalTrials.gov study NCT04626388. IPD Sharing: Not stated. Countries: 1. Publications: 5.
How the Precise Habitats Can Predict the IDH Mutation Status and Prognosis of the Patients With High-grade Gliomas
ClinicalTrials.gov study NCT04908267. IPD Sharing: NO. Countries: 1. Publications: 1.
NGAL and Renal Resistive Index in the Diagnosis and Prognosis of Sepsis-associated AKI
ClinicalTrials.gov study NCT05374759. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Factors and Prognosis of Obstructive Pyelonephritis Patients
ClinicalTrials.gov study NCT06299215. IPD Sharing: Not stated. Countries: 1. Publications: 10.
CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
ClinicalTrials.gov study NCT00400075. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of changes in MS diagnostic criteria over 25 years on time to treatment and prognosis in patients with clinically isolated syndrome
Open the record for dataset details and reuse information.
Data from: CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma
Open the record for dataset details and reuse information.
Data from: Axial myopia is associated with visual field prognosis of primary open-angle glaucoma
Open the record for dataset details and reuse information.
Data from: Neoadjuvant and concurrent chemotherapy have varied impacts on the prognosis of patients with the ascending and descending types of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
Open the record for dataset details and reuse information.
Data from: Analysis of altered level of blood-based biomarkers in the prognosis of COVID-19 patients
Open the record for dataset details and reuse information.
Data from: Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis
Open the record for dataset details and reuse information.
Relationship between c-reactive protein-albumin ratio and prognosis in pediatric patients with severe burns
Open the record for dataset details and reuse information.
Deep learning to estimate durable clinical benefit and prognosis from patients with non-small cell lung cancer treated with PD-1/PD-L1 blockade
Open the record for dataset details and reuse information.
Data from: Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients
Open the record for dataset details and reuse information.
Data from: Alzheimer Disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal
<p>Objective: To identify potential predictors for outcome in individuals with mild cognitive impairment (MCI) who have reverted to normal cognition (NC).</p> <p>Methods: We selected individuals with MCI, who reverted at follow-up to NC, with follow-up after reversion from ADNI. Common clinical markers, AD biomarkers, and neurodegeneration imaging markers were used to compare MCI reverters based on subsequent clinical outcome (i.e. subsequent decline or stable reversion). For independent comparison, findings of the clinical Amsterdam Dementia Cohort are presented.</p> <p>Results: Seventy-seven (10%) out of 757 individuals with MCI reverted to NC and 61 individuals of these had follow-up data available. After 3.2±2.2 years 16 (24%) progressed to MCI, and 3 (5%) to dementia. Those who declined were older and had a higher amyloid PET burden and higher cerebrospinal fluid (CSF) tau levels.</p> <p>Conclusion: In MCI reverters, abnormal biomarkers for AD pathology are associated with subsequent decline. AD biomarkers may aid in the prognosis of reverting MCI.</p>
Data from: Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis
Gastric cancer is the second most common cause of cancer-related mortality worldwide. Accurate prediction of disease progression is difficult, and new biomarkers for clinical use are essential. Recently, we reported that the proteasome-associated deubiquitinating enzyme UCHL5/Uch37 is a new prognostic marker in both rectal cancer and pancreatic ductal adenocarcinoma. Here, we have assessed by immunohistochemistry UCHL5 tumor expression in gastric cancer. The study cohort comprised 650 patients, who underwent surgery in Helsinki University Hospital, Finland, between 1983 and 2009. We investigated the association of cytoplasmic UCHL5 tumor expression to assess clinicopathological parameters and patient survival. Positive cytoplasmic UCHL5 tumor immunoexpression is linked to increased survival of patients with small (<5 cm) tumors (p = 0.001), disease stages I-II (p = 0.025), and age 66 years or older (p = 0.037). UCHL5 is thus a potential marker in gastric cancer with new prognostic relevance.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.